Skip navigation

  • Please visit the Pure Research Information Portal for further information
  • Identification of TIAM1 as a Potential Synthetic-Lethal-like Gene in a Defined Subset of Hepatocellular Carcinoma, Permtermsin, C., Lalchungnunga, H., Nakjang, S., Casement, J., Ogle, L., Reeves, H., Strathdee, G., Shukla, R., Welsh, M. 28 Mar 2023, In: International Journal of Molecular Sciences
  • Impact of retrotransposon protein L1 ORF1p expression on oncogenic pathways in hepatocellular carcinoma: the role of cytoplasmic PIN1 upregulation, Zadran, B., Sudhindar, P., Wainwright, D., Bury, Y., Luli, S., Howarth, R., McCain, M., Watson, R., Huet, H., Palinkas, F., Palmini, R., Casement, J., Mann, D., Oakley, F., Lunec, J., Reeves, H., Faulkner, G., Shukla, R. 30 Mar 2023, In: British Journal of Cancer
  • Regulation of CHK1 inhibitor resistance by a c-Rel and USP1 dependent pathway, Hunter, J., Campbell, A., Hannaway, N., Kerridge, S., Luli, S., Butterworth, J., Sellier, H., Mukherjee, R., Dhillon, N., Sudhindar, P., Shukla, R., Brownridge, P., Bell, H., Coxhead, J., Taylor, L., Leary, P., Hasoon, M., Collins, I., Garrett, M., Eyers, C., Perkins, N. 14 Oct 2022, In: Biochemical Journal
  • Sulfatase-2 from Cancer Associated Fibroblasts: An Environmental Target for Hepatocellular Carcinoma?, Zaki, M., Alhasan, S., Shukla, R., McCain, M., Laszczewska, M., Geh, D., Patman, G., Televantou, D., Whitehead, A., Maurício, J., Barksby, B., Gee, L., Paish, H., Leslie, J., Younes, R., Burt, A., Borthwick, L., Thomas, H., Beale, G., Govaere, O., Sia, D., Anstee, Q., Tiniakos, D., Oakley, F., Reeves, H. 13 Dec 2022, In: Liver Cancer
  • A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC?, Eldafashi, N., Darlay, R., Shukla, R., McCain, M., Watson, R., Liu, Y., McStraw, N., Fathy, M., Fawzy, M., Zaki, M., Daly, A., Maurício, J., Burt, A., Haugk, B., Cordell, H., Bianco, C., Dufour, J., Valenti, L., Anstee, Q., Reeves, H. 19 Mar 2021, In: Cancers
  • HCV activates somatic L1 retrotransposition—a potential hepatocarcinogenesis pathway, Sudhindar, P., Wainwright, D., Saha, S., Howarth, R., McCain, M., Bury, Y., Saha, S., McPherson, S., Reeves, H., Patel, A., Faulkner, G., Lunec, J., Shukla, R. 11 Oct 2021, In: Cancers
  • Key features of the environment promoting liver cancer in the absence of cirrhosis, Zaki, M., Mahdi, A., Patman, G., Whitehead, A., Maurício, J., McCain, M., Televantou, D., Abou-Beih, S., Ramon-Gil, E., Watson, R., Cox, C., Leslie, J., Wilson, C., Govaere, O., Lunec, J., Mann, D., Nakjang, S., Oakley, F., Shukla, R., Anstee, Q., Tiniakos, D., Reeves, H. 1 Dec 2021, In: Scientific Reports
  • L1 retrotransposition is a common feature of mammalian hepatocarcinogenesis, Schauer, S., Carreira, P., Shukla, R., Gerhardt, D., Gerdes, P., Sanchez-Luque, F., Nicoli, P., Kindlova, M., Ghisletti, S., Dos Santos, A., Rapoud, D., Samuel, D., Faivre, J., Ewing, A., Richardson, S., Faulkner, G. May 2018, In: Genome Research
  • Mutual epithelium-macrophage dependency in liver carcinogenesis mediated by ST18, Ravà, M., D'Andrea, A., Doni, M., Kress, T., Ostuni, R., Bianchi, V., Morelli, M., Collino, A., Ghisletti, S., Nicoli, P., Recordati, C., Iascone, M., Sonzogni, A., D'Antiga, L., Shukla, R., Faulkner, G., Natoli, G., Campaner, S., Amati, B. May 2017, In: Hepatology
  • Reprogramming triggers endogenous L1 and Alu retrotransposition in human induced pluripotent stem cells, Klawitter, S., Fuchs, N., Upton, K., Muñoz-Lopez, M., Shukla, R., Wang, J., Garcia-Cañadas, M., Lopez-Ruiz, C., Gerhardt, D., Sebe, A., Grabundzija, I., Merkert, S., Gerdes, P., Pulgarin, J., Bock, A., Held, U., Witthuhn, A., Haase, A., Sarkadi, B., Löwer, J., Wolvetang, E., Martin, U., Ivics, Z., Izsvák, Z., Garcia-Perez, J., Faulkner, G., Schumann, G. 8 Jan 2016, In: Nature Communications

PhD December 20 2007

Back to top